• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症状态下的小、大胆管细胞和小、大导管型肝内胆管癌中铁处理的不同。

Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.

机构信息

Department of Anatomical, Histological, Forensic Medicine and Orthopedic Sciences, Sapienza University of Rome.

Department of Biosciences and Territory, University of Molise, Pesche (IS).

出版信息

Eur J Histochem. 2020 Oct 19;64(4):3156. doi: 10.4081/ejh.2020.3156.

DOI:10.4081/ejh.2020.3156
PMID:33131269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7586138/
Abstract

Cholangiocarcinoma (CCA) represents the second most common primary hepatic malignancy and originates from the neoplastic transformation of the biliary cells. The intrahepatic subtype includes two morpho-molecular forms: large-duct type intrahepatic CCA (iCCA) and small-duct type iCCA. Iron is fundamental for the cellular processes, contributing in tumor development and progression. The aim of this study was to evaluate iron uptake, storage, and efflux proteins in both lipopolysaccharide-inflamed small and large cholangiocytes as well as in different iCCA subtypes. Our results show that, despite an increase in interleukin-6 production by both small and large cholangiocytes, ferroportin (Fpn) was decreased only in small cholangiocytes, whereas transferrin receptor-1 (TfR1) and ferritin (Ftn) did not show any change. Differently from in vitro models, Fpn expression was increased in malignant cholangiocytes of small-duct type iCCA in comparison to large-duct type iCCA and peritumoral tissues. TfR1, Ftn and hepcidin were enhanced, even if at different extent, in both malignant cholangiocytes in comparison to the surrounding samples. Lactoferrin was higher in large-duct type iCCA in respect to small-duct type iCCA and peritumoral tissues. These findings show a different iron handling by inflamed small and large cholangiocytes, and small and large-duct type iCCA. The difference in iron homeostasis by the iCCA subtypes may have implications for the tumor management.

摘要

胆管癌(CCA)是第二大常见的原发性肝恶性肿瘤,起源于胆管细胞的肿瘤性转化。肝内型包括两种形态-分子形式:大导管型肝内 CCA(iCCA)和小胆管型 iCCA。铁对于细胞过程至关重要,有助于肿瘤的发生和发展。本研究旨在评估脂多糖诱导的小胆管和大胆管细胞以及不同 iCCA 亚型中铁的摄取、储存和外排蛋白。我们的结果表明,尽管小胆管和大胆管细胞的白细胞介素-6 产生增加,但铁蛋白(Fpn)仅在小胆管细胞中减少,而转铁蛋白受体-1(TfR1)和铁蛋白(Ftn)没有任何变化。与体外模型不同的是,与大导管型 iCCA 和肿瘤周围组织相比,小导管型 iCCA 中的恶性胆管细胞中 Fpn 表达增加。TfR1、Ftn 和hepcidin 在恶性胆管细胞中均增强,尽管程度不同。与小导管型 iCCA 和肿瘤周围组织相比,大导管型 iCCA 中的乳铁蛋白水平更高。这些发现表明,炎症小胆管和大胆管细胞以及小胆管和大导管型 iCCA 中铁的处理方式不同。iCCA 亚型中铁稳态的差异可能对肿瘤的治疗有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d3/7586138/7e7a2efb0731/ejh-64-4-3156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d3/7586138/e21585c26850/ejh-64-4-3156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d3/7586138/945c9f79f917/ejh-64-4-3156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d3/7586138/7e7a2efb0731/ejh-64-4-3156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d3/7586138/e21585c26850/ejh-64-4-3156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d3/7586138/945c9f79f917/ejh-64-4-3156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47d3/7586138/7e7a2efb0731/ejh-64-4-3156-g003.jpg

相似文献

1
Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.炎症状态下的小、大胆管细胞和小、大导管型肝内胆管癌中铁处理的不同。
Eur J Histochem. 2020 Oct 19;64(4):3156. doi: 10.4081/ejh.2020.3156.
2
Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.胆管癌干细胞中铁代谢的失调。
Sci Rep. 2017 Dec 15;7(1):17667. doi: 10.1038/s41598-017-17804-1.
3
An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.免疫组化染色 C 反应蛋白、N-钙黏蛋白和 S100 钙结合蛋白 P 有助于肝内胆管癌分型。
Hum Pathol. 2021 Mar;109:45-52. doi: 10.1016/j.humpath.2020.12.005. Epub 2020 Dec 13.
4
Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma.表皮生长因子样结构域多重 7(EGFL7):在胆管癌中的表达及其对胆管上皮细胞生长的可能影响
Eur J Histochem. 2018 Nov 30;62(4):2971. doi: 10.4081/ejh.2018.2971.
5
Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities.肝内胆管癌:典型特征、罕见变异及存在争议的相关实体
Hum Pathol. 2023 Feb;132:197-207. doi: 10.1016/j.humpath.2022.06.001. Epub 2022 Jun 11.
6
Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.原发性硬化性胆管炎发病机制和胆管癌发生中的胆管细胞。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1390-1400. doi: 10.1016/j.bbadis.2017.08.020. Epub 2017 Aug 25.
7
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.胆管腺瘤可能是小胆管型肝内胆管癌的前驱病变。
Histopathology. 2021 Jan;78(2):310-320. doi: 10.1111/his.14222. Epub 2020 Sep 15.
8
Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes.整合分析揭示了肝内胆管癌亚型的不同特征。
Liver Int. 2024 Sep;44(9):2477-2493. doi: 10.1111/liv.16015. Epub 2024 Jun 25.
9
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures.小胆管型和大胆管型肝内胆管癌呈现出不同的免疫特征模式。
J Cancer Res Clin Oncol. 2024 Jul 22;150(7):357. doi: 10.1007/s00432-024-05888-y.
10
Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.FXR 或 TGR5 激活对胆管癌进展的差异影响。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1335-1344. doi: 10.1016/j.bbadis.2017.08.016. Epub 2017 Sep 13.

引用本文的文献

1
The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.肿瘤微环境刺激在调控肝癌干细胞代谢重编程中的新作用
Cancers (Basel). 2022 Dec 20;15(1):5. doi: 10.3390/cancers15010005.
2
A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma.一种涵盖肝内胆管癌所有阶段的新预后模型。
J Clin Transl Hepatol. 2022 Apr 28;10(2):254-262. doi: 10.14218/JCTH.2021.00099. Epub 2021 Jul 7.
3
Twenty years of histochemistry in the third millennium, browsing the scientific literature.

本文引用的文献

1
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
2
Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin.病毒性肝炎与铁代谢失调:分子途径及乳铁蛋白的作用
Molecules. 2020 Apr 24;25(8):1997. doi: 10.3390/molecules25081997.
3
Influence of oral administration mode on the efficacy of commercial bovine Lactoferrin against iron and inflammatory homeostasis disorders.
第三个千年的 20 年组织化学,浏览科学文献。
Eur J Histochem. 2020 Dec 29;64(4):3213. doi: 10.4081/ejh.2020.3213.
口服给药方式对商业牛乳铁蛋白治疗铁和炎症内稳态紊乱疗效的影响。
Biometals. 2020 Jun;33(2-3):159-168. doi: 10.1007/s10534-020-00236-2. Epub 2020 Apr 9.
4
Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action.乳铁蛋白的抗癌特性:安全性、选择性和广泛的作用范围。
Biomolecules. 2020 Mar 15;10(3):456. doi: 10.3390/biom10030456.
5
Native and iron-saturated bovine lactoferrin differently hinder migration in a model of human glioblastoma by reverting epithelial-to-mesenchymal transition-like process and inhibiting interleukin-6/STAT3 axis.天然和铁饱和牛乳铁蛋白通过逆转上皮间质转化样过程和抑制白细胞介素-6/STAT3 轴,以不同的方式抑制人神经胶质瘤的迁移。
Cell Signal. 2020 Jan;65:109461. doi: 10.1016/j.cellsig.2019.109461. Epub 2019 Nov 1.
6
Aerosolized Bovine Lactoferrin Counteracts Infection, Inflammation and Iron Dysbalance in A Cystic Fibrosis Mouse Model of Chronic Lung Infection.雾化牛乳铁蛋白可对抗慢性肺部感染的囊性纤维化小鼠模型中的感染、炎症和铁失衡。
Int J Mol Sci. 2019 Apr 30;20(9):2128. doi: 10.3390/ijms20092128.
7
Lactoferrin in Aseptic and Septic Inflammation.乳铁蛋白在无菌性和感染性炎症中的作用。
Molecules. 2019 Apr 3;24(7):1323. doi: 10.3390/molecules24071323.
8
Anatomical, histomorphological and molecular classification of cholangiocarcinoma.胆管癌的解剖学、组织形态学和分子分类。
Liver Int. 2019 May;39 Suppl 1:7-18. doi: 10.1111/liv.14093.
9
Cholangiocyte pathobiology.胆管细胞病理生物学。
Nat Rev Gastroenterol Hepatol. 2019 May;16(5):269-281. doi: 10.1038/s41575-019-0125-y.
10
Iron Metabolism in Cancer.癌症中的铁代谢。
Int J Mol Sci. 2018 Dec 27;20(1):95. doi: 10.3390/ijms20010095.